StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19+0.00 (+1.30%)

Close on Nov 17, 2026Market cap $2.39MP/E –Yield –

20/20 Biolabs market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

20/20 Biolabs's market cap was $2.76M on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.76M–

More 20/20 Biolabs figures

See a number that looks wrong?